UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

European journal of cancer (1990), 2019-07, Vol.116, p.207-215

2019

Volltextzugriff (PDF)

Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry

Journal of the American Academy of Dermatology, 2012-01, Vol.66 (1), p.37-45

2012

Volltextzugriff (PDF)

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma

Journal of the American Academy of Dermatology, 2007-10, Vol.57 (4), p.616-621

2007

Volltextzugriff (PDF)

Incidence, mortality and trends of cutaneous squamous cell carcinoma in Germany, the Netherlands, and Scotland

European journal of cancer (1990), 2023-04, Vol.183, p.60-68

2023

Volltextzugriff (PDF)

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

European journal of cancer (1990), 2016-06, Vol.60, p.190-209

2016

Volltextzugriff (PDF)

Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)

European journal of cancer (1990), 2019-06, Vol.114, p.117-127

2019

Volltextzugriff (PDF)

Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients

Journal of the American Academy of Dermatology, 2009-05, Vol.60 (5), p.863-868

2009

Volltextzugriff (PDF)

Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma

European journal of cancer (1990), 2019-03, Vol.109, p.61-69

2019

Volltextzugriff (PDF)

Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma

European journal of cancer (1990), 2020-01, Vol.125, p.38-45

2020

Volltextzugriff (PDF)

Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection

European journal of cancer (1990), 2018-11, Vol.104, p.137-144

2018

Volltextzugriff (PDF)

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

The Lancet (British edition), 2023-09, Vol.402 (10404), p.798-808

2023

Volltextzugriff (PDF)

Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients

European journal of cancer (1990), 2017-03, Vol.73, p.61-70

2017

Volltextzugriff (PDF)

COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma

European journal of cancer (1990), 2024-06, Vol.204, p.114073, Article 114073

2024

Volltextzugriff (PDF)

Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab

European journal of cancer (1990), 2016-09, Vol.64, p.116-126

2016

Volltextzugriff (PDF)

CT imaging of bone and bone marrow infiltration in malignant melanoma—Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT

European journal of radiology, 2016-04, Vol.85 (4), p.732-738

2016

Volltextzugriff (PDF)

443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011

European journal of cancer (1990), 2015-05, Vol.51 (7), p.861-868

2015

Volltextzugriff (PDF)

The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival

European journal of cancer (1990), 2018-03, Vol.91, p.1-10

2018

Volltextzugriff (PDF)

Borrelia burgdorferi—associated cutaneous B cell lymphoma: Clinical and immunohistologic characterization of four cases

Journal of the American Academy of Dermatology, 1991-04, Vol.24 (4), p.584-590

1991

Volltextzugriff (PDF)

Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: An open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study

European journal of cancer (1990), 2013-01, Vol.49 (1), p.166-174

2013

Volltextzugriff (PDF)

Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma

European journal of cancer (1990), 2006-02, Vol.42 (3), p.342-350

2006

Volltextzugriff (PDF)

Modified ABC-point list of dermoscopy: A simplified and highly accurate dermoscopic algorithm for the diagnosis of cutaneous melanocytic lesions

Journal of the American Academy of Dermatology, 2003-05, Vol.48 (5), p.672-678

2003

Volltextzugriff (PDF)

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF V600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis

European journal of cancer (1990), 2017-07, Vol.79, p.176-184

2017

Volltextzugriff (PDF)

An open-label, multicentre safety study of vemurafenib in patients with BRAF V600 -mutant metastatic melanoma: final analysis and a validated prognostic scoring system

European journal of cancer (1990), 2019-01, Vol.107, p.175

2019

Volltextzugriff (PDF)

Predictors of the Use of Sunscreen in Dermatological Patients in Central Europe

Preventive medicine, 2000-08, Vol.31 (2), p.134-139

2000

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektioneBooks on EBSCOhost

Zeitschrift / SerieJournal Of Clinical Oncology

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(31)
IngentaConnect
(31)
Elsevier ScienceDirect Journals Complete
(31)
IngentaConnect Journals
(10)
Journals@Ovid Ovid Full Text
(8)
Publisher or Other Site
(8)
EBSCOhost Business Source Ultimate
(1)
EBSCOhost Psychology and Behavioral Sciences Collection
(1)

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

European Journal Of Cancer
(19)
Journal Of The American Academy Of Dermatology
(7)
Clinics In Dermatology
(1)
European Journal Of Radiology
(1)
J Am Acad Dermatol
(1)
J Clin Epidemiol
(1)
Journal Of Clinical Epidemiology
(1)
Preventive Medicine
(1)
The Lancet
(1)

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma

Incidence, mortality and trends of cutaneous squamous cell carcinoma in Germany, the Netherlands, and Scotland

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)

Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients

Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma

Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials

Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma

Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients

COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma

Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab

CT imaging of bone and bone marrow infiltration in malignant melanoma—Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT

443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011

The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival

Borrelia burgdorferi—associated cutaneous B cell lymphoma: Clinical and immunohistologic characterization of four cases

Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: An open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study

Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma

Modified ABC-point list of dermoscopy: A simplified and highly accurate dermoscopic algorithm for the diagnosis of cutaneous melanocytic lesions

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF V600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis

An open-label, multicentre safety study of vemurafenib in patients with BRAF V600 -mutant metastatic melanoma: final analysis and a validated prognostic scoring system

Predictors of the Use of Sunscreen in Dermatological Patients in Central Europe

Aktive Filter

Suchergebnisse filtern